alexa Anti Hyperglycemic Activity of Elytraria Acaulis Lind.
ISSN: 2167-0412

Medicinal & Aromatic Plants
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Anti Hyperglycemic Activity of Elytraria Acaulis Lind. on Streptozotocin-Induced Diabetic Rats

Ruby K Koshy1,2*, Raj Kapoor B2 and Mohammad Azamthulla1
1Department of Pharmacology, Karpagam University, Coimbatore, Tamilnadu, India
2The Oxford college of Pharmacy, Begur Road, Hongasandra, Bangalore, Karnataka, India
Corresponding Author : Ruby K. Koshy
assistant Professor
Department of Pharmacology
The Oxford college of Pharmacy
Bangalore, Karnataka, India
Tel: 09448367265
E-mail: [email protected]
Received January 24, 2012; Accepted May 11, 2012; Published May 18, 2012
Citation: Koshy RK, Raj Kapoor B, Azamthulla M (2012) Anti Hyperglycemic Activity of Elytraria Acaulis Lind. on Streptozotocin-Induced Diabetic Rats. Med Aromat Plants 1:103. doi: 10.4172/2167-0412.1000103
Copyright: © 2012 Koshy RK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 

Abstract

Aim of the present work is to evaluate the Anti-hyperglycemic activity of Elytraria acaulis Lind. on streptozotocininduced diabetic rats. Elytraria acaulis Lind. belongs to family Acanthaceae which is a small shrub, that grows in shady dry places. The whole plant is used for medicinal purposes. Diabetes was induced in rats by administering streptozotocin (60 mg/kg) intraperitonially. Animals were divided into five groups (n=6) receiving different treatments: Group I: vehicle (Control), Group II: diabetic (control), Groups III and IV: Elytraria acaulis Lind. extract treated (200 and 400 mg/kg, orally respectively) and Group V: standard anti diabetic drug glibenclamide (500 mcg/kg, orally). Blood serum was analyzed for the following biochemical parameters like blood glucose level, oral glucose tolerate test, body
weight and liver glycogen & glycated hemoglobin levels. Histopathological study of pancreas, liver and kidney was examined. The Elytraria acaulis Lind. extracts were effective in decreasing blood glucose level, increases oral glucose tolerance test, moderately alteration in body weight and there was a marked reduction in the liver glycogen levels and reduction in glycated hemoglobin levels. Histopathological study, showing improvement with nearly normal islets of
langerhans, showing marked improvement with normal architecture with mild hepatocytes degeneration and showing acid significantly inhibited glomerular hypertrophy, glomerulosclerosis. It is concluded that, the anti-hyperglycemic effect of methanolic extracts of Elytraria acaulis Lind. may be due to both reductions in glucose level and improvement
in Histopathological studies. The methanolic extract of Elytraria acaulis Lind. at the dose level of 400 mg/kg produced more significant reduction in glucose level when compare with low dose 200 mg/kg. Hence, it is proved that Elytraria acaulis Lind. is having anti diabetic activity in streptozotocin induced diabetic rats.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords